BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10024694)

  • 1. Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor.
    Zagon IS; Smith JP; McLaughlin PJ
    Int J Oncol; 1999 Mar; 14(3):577-84. PubMed ID: 10024694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor.
    McLaughlin PJ; Zagon IS; Skitzki J
    Int J Oncol; 1999 Feb; 14(2):373-80. PubMed ID: 9917516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor.
    McLaughlin PJ; Levin RJ; Zagon IS
    Int J Oncol; 1999 May; 14(5):991-8. PubMed ID: 10200353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.
    Bisignani GJ; McLaughlin PJ; Ordille SD; Beltz MS; Jarowenko MV; Zagon IS
    J Urol; 1999 Dec; 162(6):2186-91. PubMed ID: 10569617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice.
    Zagon IS; Hytrek SD; Smith JP; McLaughlin PJ
    Cancer Lett; 1997 Jan; 112(2):167-75. PubMed ID: 9066724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    Zagon IS; McLaughlin PJ
    Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.
    Zagon IS; Hytrek SD; McLaughlin PJ
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R511-8. PubMed ID: 8853370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid growth factor regulates the cell cycle of human neoplasias.
    Zagon IS; Roesener CD; Verderame MF; Ohlsson-Wilhelm BM; Levin RJ; McLaughlin PJ
    Int J Oncol; 2000 Nov; 17(5):1053-61. PubMed ID: 11029512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.
    Zagon IS; Smith JP; Conter R; McLaughlin PJ
    Int J Mol Med; 2000 Jan; 5(1):77-84. PubMed ID: 10601579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid growth factor and organ development in rat and human embryos.
    Zagon IS; Wu Y; McLaughlin PJ
    Brain Res; 1999 Aug; 839(2):313-22. PubMed ID: 10519055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
    McLaughlin PJ; Zagon IS; Park SS; Conway A; Donahue RN; Goldenberg D
    BMC Cancer; 2009 Oct; 9():369. PubMed ID: 19835629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer.
    Zagon IS; Hytrek SD; Lang CM; Smith JP; McGarrity TJ; Wu Y; McLaughlin PJ
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R780-6. PubMed ID: 8853403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
    Zagon IS; Wu Y; McLaughlin PJ
    J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.
    Donahue RN; McLaughlin PJ; Zagon IS
    Am J Physiol Regul Integr Comp Physiol; 2009 Jun; 296(6):R1716-25. PubMed ID: 19297547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation.
    Cheng F; McLaughlin PJ; Banks WA; Zagon IS
    Am J Physiol Regul Integr Comp Physiol; 2010 Sep; 299(3):R774-85. PubMed ID: 20592180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid growth factor and the treatment of human pancreatic cancer: a review.
    Zagon IS; McLaughlin PJ
    World J Gastroenterol; 2014 Mar; 20(9):2218-23. PubMed ID: 24605021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.
    Zagon IS; McLaughlin PJ
    Int J Oncol; 2006 Aug; 29(2):489-94. PubMed ID: 16820893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.
    Zagon IS; Porterfield NK; McLaughlin PJ
    Exp Biol Med (Maywood); 2013 Jun; 238(6):589-99. PubMed ID: 23918871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.
    Wilson RP; McLaughlin PJ; Lang CM; Zagon IS
    Cell Prolif; 2000 Apr; 33(2):63-73. PubMed ID: 10845251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor in head and neck squamous cell carcinoma.
    Levin RJ; Wu Y; McLaughlin PJ; Zagon IS
    Laryngoscope; 1997 Mar; 107(3):335-9. PubMed ID: 9121309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.